🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael R. Jordan

Tufts Medical Center

ORCID: 0000-0002-2177-0405

Also affiliated with Instituto de Medicina Tropical

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.1Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

PLoS ONE(2023)10.1371/journal.pone.0286297
Top 16%
1.3DataRank
Top 16%62 citations

Tanayott Thaweethai, Shari B. Brosnahan, Mine Cicek, Megan L. Fitzgerald, Jason D. Goldman +95 more

Papers

Driven by 20 papers — median percentile 80. Top paper: “Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design”.

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

PLoS ONE(2023)10.1371/journal.pone.0286297
Top 16%
1.3DataRank
Top 16%62 citations

Tanayott Thaweethai, Shari B. Brosnahan, Mine Cicek, Megan L. Fitzgerald, Jason D. Goldman +95 more

Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in Cameroon

PLoS ONE(2020)10.1371/journal.pone.0230988
N/A
0.840DataRank · unranked
13 citations

Rogers Ajeh, Isidore Sieleunou, Jackson Jr Nforbewing Ndenkeh, Michael R. Jordan, Nadia A. Sam‐Agudu +3 more

Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

PLOS Medicine(2015)10.1371/journal.pmed.1001810
N/A
0.816DataRank · unranked
229 citations

Jose Luis Blanco, Michael R. Jordan, Jonathan Taylor, Philippe Lemey, Vici Varghese +88 more

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review

The Lancet Microbe(2022)10.1016/s2666-5247(21)00250-0
Top 25%
0.804DataRank
Top 25%22 citations

Seble Kassaye, Michael R. Jordan, Vinie Kouamou, David Katzenstein, Robert W. Shafer +1 more

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

PLOS Medicine(2015)10.1371/journal.pmed.1001845
N/A
0.489DataRank · unranked
25 citations

Jose Luis Blanco, Michael R. Jordan, Jonathan Taylor, Philippe Lemey, Vici Varghese +89 more

Recommendations on data sharing in HIV drug resistance research

PLOS Medicine(2023)10.1371/journal.pmed.1004293
N/A
0.360DataRank · unranked
10 citations

Mark J. Siedner, Susan J. Little, Santiago Ávila‐Ríos, Alisen Ayitewala, Ronald J. Bosch +50 more

Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia

PLoS ONE(2022)10.1371/journal.pone.0266438
N/A
0DataRank · unranked
13 citations

Anna Winston, Nicholus Mutenda, Ndapewa Hamunime, Tuhin S. Roy, Christine Wanke +3 more

HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates

Journal of the International AIDS Society(2020)10.1002/jia2.25611
N/A
0DataRank · unranked
69 citations

Seble Kassaye, Geoffrey Barrow, Jagadish Chandrabose Sundaramurthi, Michael R. Jordan, Robert W. Shafer +1 more

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi

Antiviral Therapy(2022)10.1177/13596535221121225
N/A
0DataRank · unranked
5 citations

Matthew Kagoli, Sikhona Chipeta, Andrew F. Auld, Joy C-W Chang, Joshua DeVos +17 more

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV(2023)10.1016/s2352-3018(22)00365-4
N/A
0DataRank · unranked
64 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver +32 more

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

Viruses(2023)10.3390/v15091932
N/A
0DataRank · unranked
53 citations

Soo‐Yon Rhee, Carolyn Chu, Ava Avalos, Amrit Ahluwalia, Ravindra K. Gupta +3 more

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Viruses(2024)10.3390/v16030399
N/A
0DataRank · unranked
56 citations

Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip Grant +6 more

Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review

medRxiv(2024)10.1101/2024.01.05.24300911
N/A
0DataRank · unranked
9 citations

Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip Grant +6 more

High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence

AIDS Research and Therapy(2025)10.1186/s12981-025-00788-8
N/A
0DataRank · unranked
8 citations

Rolando Lorenzana, Michael Pickles, Seth Inzaule, Michael R. Jordan, Sheilee Díaz +2 more

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field

The Lancet Microbe(2025)10.1016/j.lanmic.2025.101076
N/A
0DataRank · unranked
11 citations

Jolynne Mokaya, Tongai Maponga, Anna Kramvis, Geoffrey Dusheiko, William L. Irving +39 more

Noncanonical HIV drug resistance mutations: need to close existing gaps

AIDS(2025)10.1097/qad.0000000000004170
N/A
0DataRank · unranked
4 citations

Michael R. Jordan, Joseph Fokam, Raph L. Hamers, Roger Paredes, Trevor A. Crowell +7 more

Clinical evaluation of patterned dried plasma spot cards to support quantification of HIV viral load and reflexive genotyping

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2419160122
N/A
0DataRank · unranked
6 citations

Keith R. Baillargeon, Monalisa Kalimashe, Vibha Kana, Hloniphile Zwane, Cheri van der Walt +11 more

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence

Clinical Infectious Diseases(2025)10.1093/cid/ciaf444
N/A
0DataRank · unranked
2 citations

Richard Lessells, Winnie Muyindike, Lyra S. Johnson, Roger D. Kouyos, Tom Loosli +10 more

Detection of single peptide with only one amino acid modification via electronic fingerprinting using reengineered durable channel of Phi29 DNA packaging motor

Biomaterials(2021)10.1016/j.biomaterials.2021.121022
N/A
0DataRank · unranked
19 citations

Miranda L. Gardner, Lakmal Jayasinghe, Michael R. Jordan, Julian Aldana, Nicolas Burns +3 more

COVID-19: How Far We’ve Come and Where We Need to Go Next

Infectious Disease Clinics of North America(2025)10.1016/j.idc.2025.03.001
N/A
0DataRank · unranked
0 citations

Michael R. Jordan, Rajesh T. Gandhi